By a News Reporter-Staff News Editor at Medical Letter on the CDC& FDA B. Braun Medical Inc., a leader in infusion therapy and pain management, announced that it has received U.S. Food and Drug Administration approval of Nutrilipid 20% for parenteral nutrition therapy in adult& pediatric patients. "We are very pleased that the FDA has granted ap
Data on Immunoglobulins Reported by Researchers at Biogen Idec, Inc.. In a common tier based approach, samples identified as ADA screen positive are confirmed for the binding specificity of the antibodies to the drug molecule via a confirmatory assay. The confirmation of specificity is generally considered as a critical step of the tier based appro
By a News Reporter-Staff News Editor at Health& Medicine Week A new study on Skin Diseases and Conditions is now available. According to news reporting from Ballerup, Denmark, by NewsRx journalists, research stated, "Development of orally available phosphodiesterase 4 inhibitors as anti-inflammatory drugs has been going on for decades.
By a News Reporter-Staff News Editor at Gene Therapy Weekly Research and Markets has announced the addition of Jain PharmaBiotech's new report "Drug Delivery in Cancer- Technologies, Markets and Companies" to their offering. Drug delivery remains a challenge in management of cancer. Approximately 12.5 million new cases of cancer are being diagnos
By a News Reporter-Staff News Editor at Gene Therapy Weekly For the first time in the world, a patient with a mechanical heart pump has taken part in a new gene therapy trial for heart failure at Harefield Hospital, London. Heart failure occurs when the heart no longer pumps blood effectively and it affects hundreds of thousands of people in the
By a News Reporter-Staff News Editor at Gene Therapy Weekly A new "route forward for therapy" for patients with Duchenne muscular dystrophy, a degenerative disease that mostly afflicts young boys, has been reported by Dr. Kevin Flanigan, principal investigator at the Center for Gene Therapy at Nationwide Children's Hospital in Columbus, Ohio.
By a News Reporter-Staff News Editor at Women's Health Weekly From Washington, D.C., NewsRx journalists report that a patent application by the inventors Ross, Ruth Alexandra; Parolaro, Daniela, filed on September 10, 2012, was made available online on August 14, 2014. The patent's assignee is Otsuka Pharmaceutical Co., Ltd.. News editors obtaine
By a News Reporter-Staff News Editor at Biotech Week Amgen and its subsidiary, Onyx Pharmaceuticals, Inc., announced that the Phase 3 clinical trial FOCUS did not meet its primary endpoint of improving overall survival. "While it is unfortunate that the FOCUS study did not meet its primary endpoint of overall survival, we believe the results fro
By a News Reporter-Staff News Editor at Biotech Week Genentech, a member of the Roche Group, announced that the U.S. Food and Drug Administration approved Avastin in combination with paclitaxel and cisplatin or paclitaxel and topotecan for the treatment of women with persistent, recurrent or metastatic carcinoma of the cervix. "With this appr
By a News Reporter-Staff News Editor at Biotech Week Flex Pharma, Inc., a biopharmaceutical company dedicated to creating innovative, novel treatments for neuromuscular disorders, announced positive clinical results of its proprietary product for preventing muscle cramps. With these positive results in healthy volunteers, we plan to initiate effi
By a News Reporter-Staff News Editor at Biotech Week Ignyta, Inc., an oncology precision medicine biotechnology company, announced company highlights and financial results for the second quarter ended June 30, 2014. "Since the beginning of the second quarter, we have continued to make solid progress toward our goal of becoming a leading precisio
By a News Reporter-Staff News Editor at Vaccine Weekly Liquidia Technologies announced that it will present new data demonstrating the influence of tunable PRINT particle characteristics on the immune response as a component of vaccine development. Results from this preclinical study will be presented at the 9th Annual ImVacS, The Immunotherap
Patent Application Titled "Compound for Inhibiting Glutathione S-Transferase Omega 1 Activity, Pharmaceutical Composition Containing Thereof, and Method for Synthesizing the Same" Published Online. By a News Reporter-Staff News Editor at Biotech Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent...
By a News Reporter-Staff News Editor at Biotech Week Merck Serono S.A. has been issued patent number 8802703, according to news reporting originating out of Alexandria, Virginia, by NewsRx editors. The patent's inventors are Goutopoulos, Andreas; Askew, Jr., Benny C.; Diep, Nhut Kiet; Karra, Srinivasa R.; Schwarz, Matthias; Yu, Henry. This patent
By a News Reporter-Staff News Editor at Journal of Engineering According to news reporting originating from Alexandria, Virginia, by VerticalNews journalists, a patent by the inventors Yao, Wenbing; Tian, Hong; Xu, Xiangyang; Li, Hairui; Dong, Yue; Gao, Xiangdong, filed on September 4, 2008, was published online on August 12, 2014. The assignee f
By a News Reporter-Staff News Editor at Biotech Week Pfizer Inc. announced that the U.S. Food and Drug Administration has accepted for review the Biologics License Application for bivalent recombinant LP2086, the company's vaccine candidate for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroup B in 10 thr
By a News Reporter-Staff News Editor at Biotech Week From Washington, D.C., NewsRx journalists report that a patent application by the inventors Sasaki, Keishin; Chase, Thomas N.; Koga, Minako, filed on February 6, 2013, was made available online on August 14, 2014. The patent's assignee is Nc Medical Research Inc.. For example, Alzheimer's disea
By a News Reporter-Staff News Editor at Biotech Week From Washington, D.C., NewsRx journalists report that a patent application by the inventors Brown, Darby C.; Brown, Kristen A., filed on December 2, 2013, was made available online on August 14, 2014. The patent's assignee is 3 B Pharmaceuticals, Inc.. News editors obtained the following quote
By a News Reporter-Staff News Editor at Biotech Week Seattle Genetics, Inc. announced the initiation of a phase 1 clinical trial evaluating SGN-CD70A for CD70-positive relapsed or refractory non-Hodgkin lymphoma and metastatic renal cell carcinoma. "CD70 is a very promising ADC antigen, which is highly expressed in both NHL and RCC, and has mini
By a News Reporter-Staff News Editor at Biotech Week Eutropics, Inc, and Tolero Pharmaceuticals, Inc, announced that clinical study results demonstrating a predictive biomarker for Chronic Lymphocytic Leukemia patient response to treatment with Toleros' experimental drug alvocidib were published in the medical journal Leukemia. The study, perform
By a News Reporter-Staff News Editor at Bioterrorism Week A patent application by the inventors Yim, Kalvin; Danso, Steven; Hausknecht, Edward, filed on April 3, 2014, was made available online on August 14, 2014, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application is assigned to PharmA
By a News Reporter-Staff News Editor at Clinical Trials Week AcelRx Pharmaceuticals, Inc.,, a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, reported financial results for the three and six months ended June 30, 2014. Since the receipt of
By a News Reporter-Staff News Editor at Clinical Trials Week BioDelivery Sciences International, Inc. announced that along with its commercial partner, Endo Pharmaceuticals, engaged in a positive pre-New Drug Application meeting with the U.S. Food and Drug Administration regarding BEMA Buprenorphine for the management of pain severe enough to req
Now a clinical trial recently approved by the National Cancer Institute will open at the University of Colorado Cancer Center and nationally via the Southwest Oncology Group to test the COXEN model in bladder cancer- can it predict which cancers will and which cancers will not respond to two common chemotherapies? If we treat a bladder cancer with.
Data on Clinical Trials and Studies Reported by Researchers at Royal Hallamshire Hospital. By a News Reporter-Staff News Editor at Clinical Trials Week Research findings on Clinical Research are discussed in a new report. The news reporters obtained a quote from the research from Royal Hallamshire Hospital, "Conventional pharmacologic and...